
389: Hims' Super Bowl fallout, and the FDA reverses course
The Readout Loud
00:00
How oral semaglutide pills work and controversy
Discussion of oral peptide formulation challenges, Wagovi's proprietary tech, and Hims' liposomal claim.
Play episode from 19:23
Transcript


